Enanta Pharmaceuticals (ENTA) FCF Margin Growth (3y) (2015 - 2026)
Enanta Pharmaceuticals (ENTA) FCF Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | 4,478.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,478.00 |
| Dec 31, 2025 | 8,829.00 |
| Sep 30, 2025 | 11,761.00 |
| Jun 30, 2025 | 24,793.00 |
| Mar 31, 2025 | -809.00 |
| Dec 31, 2024 | -6,521.00 |
| Sep 30, 2024 | -2,513.00 |
| Jun 30, 2024 | 7,218.00 |
| Mar 31, 2024 | -15,788.00 |
| Dec 31, 2023 | -9,396.00 |
| Sep 30, 2023 | -989.00 |
| Jun 30, 2023 | -17,716.00 |
| Mar 31, 2023 | -14,098.00 |
| Dec 31, 2022 | -17,373.00 |
| Sep 30, 2022 | -9,129.00 |
| Jun 30, 2022 | -16,215.00 |
| Mar 31, 2022 | -21,446.00 |
| Dec 31, 2021 | -9,091.00 |
| Sep 30, 2021 | -13,127.00 |
| Jun 30, 2021 | -14,412.00 |